ASN-7350, a highly selective FGFR2/3 dual inhibitor, for FGFR2/FGFR3 driven solid tumors
用户qF7pME5zq23w
11天前
67
10
已关闭
DOI:
文献链接:
其他信息:
Q Sun, J Guan, H Song, J Lv, P Zeng, M Wang…
Cancer …, 2025
aacrjournals.org
… FGFR2 kinase domain mutations in FGFR2-altered cholangiocarcinoma, and 13-25% of
patients develop FGFR3 … in treating multiple solid tumors harboring FGFR2/3 alterations. ASN-…

